0000000000653593

AUTHOR

H. Tesch

showing 4 related works from this author

Generation and release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by arachidonic acid

1978

This study describes the generation and release of an eosinophil chemotactic factor from human polymorphonuclear neutrophils, rat basophilic leukemia cells, and from a lymphocyte monocyte basophil suspension by arachidonic acid (AA). The eosinophil chemotactic factor (ECF) is highly specific for eosinophils and resembles the ECF activity obtained from human polymorpho-nuclear neutrophils after stimulation with the Ca ionophore or during phagocytosis. In this regard, AA-induced ECF represents a biological activity distinct from oxidized AA and its conversion products. AA may therefore have a dual function: it represents an important mechanism of cell activation; as AA is converted into prost…

NeutrophilsPhagocytosisGuinea PigsImmunologyArachidonic AcidsIn Vitro TechniquesBasophilBiologychemistry.chemical_compoundPhagocytosismedicineAnimalsHumansImmunology and AllergyCalcimycinMonocyteChemotaxisBiological activityEosinophilRatsEosinophilsChemotaxis Leukocytemedicine.anatomical_structurechemistryBiochemistryArachidonic acidCell activationEuropean Journal of Immunology
researchProduct

Generation of an Eosinophilotactic Factor from Human PMNs by Various Mechanisms of Cell Activation

1979

It is well established that an increase in the number of eosinophils both in tissue and in the circulation is a feature of many clinical conditions based on delayed (1,2) and immediate type hypersensitivity reactions (3,4). Since eosinophils have been recognised to exert specific killer function on parasites (5) and to be prominent participants at sites of inflammation, the mechanisms of their chemo-attraction are of major importance. In immediate type hypersensitivity reactions, eosinophils have been demonstrated to counteract the mediators of inflammation such as histamine (6), the SRS-A (7) and the platelet aggregating factor (8).

business.industryPlatelet Aggregating FactorEnzyme releaseInflammationMast cellchemistry.chemical_compoundmedicine.anatomical_structurechemistryImmunologyMedicineArachidonic acidmedicine.symptombusinessCell activationHistamineFunction (biology)
researchProduct

Phospholipase A2 and arachidonic acid: a common link in the generation of the eosinophil chemotactic factor (ECF) from human PMN by various stimuli.

1980

An eosinophil chemotactic factor (ECF) of low molecular weight can be generated and released from human polymorphonuclear neutrophils by the calcium ionophore, phagocytosis of zymosan particles, arachidonic acid, and phospholipase A2. Since the activation of cells by the ionophore and during the phagocytic event leads to phospholipid turnover, with the subsequent generation of arachidonic acid, it is reasonable that phospholipase A2 represents the common link for ECF production. The kinetics of ECF release by phospholipase A2 is similar to the pattern observed with the various stimuli. After a rapid rise in activity a decline occurred at later times of secretion, suggesting a mechanism of i…

NeutrophilsPhagocytosisChemotactic Factors EosinophilImmunologyPhospholipidArachidonic AcidsBiologyPhospholipases Achemistry.chemical_compoundLipoxygenasePhospholipase A2Phospholipase DHumansCalcimycinCells CulturedChemotactic FactorsZymosanZymosanChemotaxisGeneral MedicineEosinophilsChemotaxis LeukocytePhospholipases A2chemistryBiochemistryPhospholipasesType C Phospholipasesbiology.proteinArachidonic acidCell fractionationSubcellular FractionsScandinavian journal of immunology
researchProduct

Initiation and Modulation of ECF Generation and Secretion from Human Polymorphonuclear NeutrophilsX.

1978

The primary mediators which are involved in inflammatory processes are histamine, the slow reacting substance of anaphylaxis (SRS-A), the platelet aggregating factor (PAF) and the eosinophil chemotactic factor (ECF). These mediators are primarily localized within mast cells and basophil leucocytes, which represent the target cells of allergic reaction. Binding of IgE to mast cells and basophil leucocytes and addition of the appropriate antigen then leads to the activation of the target cells with a subsequent release of their mediators. SRS and ECF have also been found in a non mast cell source, e.g. in human PMNs. ECF can be generated and released from human PMNs by different stimuli, such…

biologyInflammationBasophilEosinophilMast cellImmunoglobulin ECell biologychemistry.chemical_compoundmedicine.anatomical_structurechemistrymedicinebiology.proteinSecretionmedicine.symptomSlow-reacting substance of anaphylaxisHistamine
researchProduct